Pure Global

ABX Pentra HbA1c WB Control - FDA Registration b34a8a521c2fb3df2dcea82104ec3118

Access comprehensive regulatory information for ABX Pentra HbA1c WB Control in the Myanmar medical device market through Pure Global AI's free database. This medical device is registered under FDA ID b34a8a521c2fb3df2dcea82104ec3118 and manufactured by HORIBA ABX SAS. The device was registered on April 19, 2022.

This page provides complete registration details including manufacturer information, authorized representative details, and regulatory compliance data from the official Myanmar FDA medical device database. Pure Global AI offers free access to Myanmar's complete medical device registry.

Free Database
Powered by Pure Global AI
FDA Official Data
b34a8a521c2fb3df2dcea82104ec3118
ABX Pentra HbA1c WB Control
FDA ID: b34a8a521c2fb3df2dcea82104ec3118
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Device Classification
Brand Name
HORIBA
Registration Information
Analysis ID
b34a8a521c2fb3df2dcea82104ec3118
Registration Date
April 19, 2022
Manufacturer
Authorized Representative